While T-cell exhaustion signatures, marked by stable methylation at IFNG and GZMB and accessible enhancers at PDCD1 and LAG3, mirror peripheral tumors, GBM uniquely integrates these programs within glial-driven tolerance networks. Here, LAG3 is linked to glioblastoma.